Close

Analyst Ratings for Regeneron Pharma (REGN) [Sells]

REGN Rating Summary

REGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on REGN
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $1,031.53 (+7.5%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/5/2022 BofA Securities
» Updated 4/4/2022
Geoff Meacham Downgrade Underperform
(Neutral)
565.00
(575.00)
616.82
(959.92)
55.62% Details
Like REGN Ratings? Also take a look at MRNA, ALNY, SNY, ABCL

REGN Ratings News